These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 36280000)

  • 21. Distinguishing Stevens-Johnson syndrome/toxic epidermal necrolysis from clinical mimickers during inpatient dermatologic consultation-A retrospective chart review.
    Weinkle A; Pettit C; Jani A; Keller J; Lu Y; Malachowski S; Trinidad JC; Kaffenberger BH; Ergen EN; Hughey LC; Smith D; Seminario-Vidal L
    J Am Acad Dermatol; 2019 Sep; 81(3):749-757. PubMed ID: 31150704
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stevens-Johnson syndrome and toxic epidermal necrolysis associated with immune checkpoint inhibitors: a systematic review.
    Zhou J; Wang CP; Li J; Zhang HL; He CX
    Front Immunol; 2024; 15():1414136. PubMed ID: 39072330
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Toxic epidermal necrolysis-like acute graft-versus-host disease in pediatric bone marrow transplant patients: Case series and review of the literature.
    Sheu Song J; Huang JT; Fraile Alonso MDC; Antaya RJ; Price HN; Funk T; Francois RA; Shah SD
    Pediatr Dermatol; 2022 Nov; 39(6):889-895. PubMed ID: 35730149
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the acute ocular manifestations of Stevens-Johnson syndrome and toxic epidermal necrolysis in Chinese eyes: a 15-year retrospective study.
    Chow LLW; Shih KC; Chan JCY; Lai JSM; Ng ALK
    BMC Ophthalmol; 2017 May; 17(1):65. PubMed ID: 28499410
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis-Like Lupus Erythematosus.
    Tankunakorn J; Sawatwarakul S; Vachiramon V; Chanprapaph K
    J Clin Rheumatol; 2019 Aug; 25(5):224-231. PubMed ID: 29912772
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Critical factors differentiating erythema multiforme majus from Stevens-Johnson syndrome (SJS)/toxic epidermal necrolysis (TEN).
    Watanabe R; Watanabe H; Sotozono C; Kokaze A; Iijima M
    Eur J Dermatol; 2011; 21(6):889-94. PubMed ID: 21873140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stevens-Johnson syndrome and toxic epidermal necrolysis in childhood-onset systemic lupus erythematosus patients: a multicenter study.
    Sakamoto AP; Silva CA; Saad-Magalhães C; Alencar AN; Pereira RMR; Kozu K; Barbosa CMPL; Terreri MT
    Acta Reumatol Port; 2017; 42(3):250-255. PubMed ID: 28375199
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A 10-year retrospective cohort study of the management of toxic epidermal necrolysis and Stevens-Johnson syndrome in a New South Wales state referral hospital from 2006 to 2016.
    Chan L; Cook DK
    Int J Dermatol; 2019 Oct; 58(10):1141-1147. PubMed ID: 30908601
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 27 years of a single burn centre experience with Stevens-Johnson syndrome and toxic epidermal necrolysis: analysis of mortality risk for causative agents.
    Weinand C; Xu W; Perbix W; Lefering R; Maegele M; Rathert M; Spilker G
    Burns; 2013 Nov; 39(7):1449-55. PubMed ID: 23702222
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differences between Stevens-Johnson syndrome versus toxic epidermal necrolysis.
    Nowsheen S; Lehman JS; El-Azhary RA
    Int J Dermatol; 2021 Jan; 60(1):53-59. PubMed ID: 33252832
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stevens Johnson syndrome-Toxic Epidermal Necrolysis Overlap induced by sulfasalazine treatment: a case report.
    Zizi N; Elmrahi A; Dikhaye S; Fihmi N; Alami Z
    Tunis Med; 2015 Jul; 93(7):413-5. PubMed ID: 26757493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improving mortality outcomes of Stevens Johnson syndrome/toxic epidermal necrolysis: A regional burns centre experience.
    Nizamoglu M; Ward JA; Frew Q; Gerrish H; Martin N; Shaw A; Barnes D; Shelly O; Philp B; El-Muttardi N; Dziewulski P
    Burns; 2018 May; 44(3):603-611. PubMed ID: 29029855
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stevens-Johnson syndrome/toxic epidermal necrolysis with severe ocular complications.
    Ueta M
    Expert Rev Clin Immunol; 2020 Mar; 16(3):285-291. PubMed ID: 32045311
    [No Abstract]   [Full Text] [Related]  

  • 34. Retrospective analysis of stevens-johnson syndrome and toxic epidermal necrolysis over a period of 10 years.
    Sanmarkan AD; Sori T; Thappa DM; Jaisankar TJ
    Indian J Dermatol; 2011 Jan; 56(1):25-9. PubMed ID: 21572786
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent advances in managing and understanding Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Hasegawa A; Abe R
    F1000Res; 2020; 9():. PubMed ID: 32595945
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute pancreatic injuries: A complication of Stevens-Johnson syndrome/toxic epidermal necrolysis associated with cytotoxic immunocell activation.
    Gao X; Tang X; Ai L; Gao Q; Liao Q; Chen M; Chen X; Zhou H; Ye Y; Li M; Han J; Wang F
    J Am Acad Dermatol; 2021 Mar; 84(3):644-653. PubMed ID: 32561372
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Harr T; French LE
    Chem Immunol Allergy; 2012; 97():149-66. PubMed ID: 22613860
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcomes in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Patients Treated With a Medicine-Led Multidisciplinary Approach.
    Lewcun JA; Vagonis A; Kontzias C; Newsom M; Drake M; Feldman MJ
    J Burn Care Res; 2024 Jan; 45(1):165-168. PubMed ID: 37698266
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disseminated intravascular coagulopathy: a complication of Stevens-Johnson syndrome/toxic epidermal necrolysis.
    El-Azhary RA; Nowsheen S; Gibson LE; DiCaudo DJ
    Int J Dermatol; 2021 Feb; 60(2):185-189. PubMed ID: 33332598
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in the Era of Systems Medicine.
    Chen CB; Wang CW; Chung WH
    Methods Mol Biol; 2022; 2486():37-54. PubMed ID: 35437717
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.